Back to top

messenger-rna: Archive

Zacks Equity Research

NVAX Starts Late-Stage Study on COVID-19-Flu Combo & Flu Vaccines

Novavax is working with the FDA to explore a pathway for accelerated approval of the COVID-19-flu combination and standalone flu vaccines.

SNYPositive Net Change PFEPositive Net Change MRNANegative Net Change NVAXPositive Net Change